Is There a Risk of Prescription of Prostate Cancer?

In sweden, we have access to these really large registries. And with that in mind, we're abled to include in thi study, nearly 350 thousand men. The patients included in the registry were those who had had a p s a check at least a year before and either did or didn't, subsequently go on five alpha reductas inhibitors. For all cause mortality, we see no association with the drug whatever. However, for prostrate cancer mortality,. we see an effect already two years of treatment. So this effect, it keeps on throughout the treatment period. They can be on the treatment for as long as ten years, according to the study design.